• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOCOMPATIBLES LTD. Y-90 THERASPHERE (3 GBQ) CANADA COMM; MICROSPHERES RADIONUCLIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOCOMPATIBLES LTD. Y-90 THERASPHERE (3 GBQ) CANADA COMM; MICROSPHERES RADIONUCLIDE Back to Search Results
Model Number 2361-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Diarrhea (1811); Fatigue (1849); Hyperbilirubinemia (1903); High Blood Pressure/ Hypertension (1908); Nausea (1970); Vomiting (2144); Thrombocytopenia (4431)
Event Date 09/09/2021
Event Type  Injury  
Event Description
It was reported via journal article that patient complications occurred.A retrospective single center study was performed with 38 child-pugh a patients with advanced/metastatic hcc.In sum, 34 received sorafenib, followed after 4 weeks by 90y gms.Analysis of safety and survival outcomes was performed to assess adverse events, median progression-free survival, and overall survival.The y-90 therasphere dose vials were referenced within the study.Grade iii-iv adverse events from the combination of sorafenib and therasphere comprised fatigue, diarrhea, nausea, vomiting, hypertension, thrombocytopenia, hyperbilirubinemia, proteinuria, hyponatremia, and elevated alanine or aspartate aminotransferase.
 
Manufacturer Narrative
Journal article: kaseb, ahmed omar, et al."a prospective phase ii study of safety and efficacy of sorafenib followed by 90y glass microspheres for patients with advanced or metastatic hepatocellular carcinoma." journal of hepatocellular carcinoma 8 (2021): 1129.Date of event = month of article submission.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Y-90 THERASPHERE (3 GBQ) CANADA COMM
Type of Device
MICROSPHERES RADIONUCLIDE
Manufacturer (Section D)
BIOCOMPATIBLES LTD.
chapman house, farnham bus prk
weydon lane
farnham, surrey
UK 
Manufacturer (Section G)
BIOCOMPATIBLES UK LIMITED
chapman house farnham bus prk
weydon lane
farnham, surrey GU9 8 QL
UK   GU9 8QL
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12994106
MDR Text Key282192023
Report Number2134265-2021-15137
Device Sequence Number1
Product Code NAW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H980006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number2361-01
Device Catalogue Number2361-01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/17/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-